- Knowledge center
Renal cell carcinoma (RCC) is the most frequent renal malignancy. An increasing number of small renal tumors – often benign – is detected, due to the widespread use of abdominal ultrasonography for check-up or clarification of non-specific symptoms. Current modalities do not allow precise discrimination of malignant tumors, often leading to overtherapy. Thus, additional diagnostic parameters could help the clinician to improve patients treatment. However, to date, no biomarker is available for clinical practice, making an accurate and non-invasive identification of RCC impossible.
"The interaction with Biogazelle was always excellent: The project was performed very quickly, communication clear and queries answered promptly. The service entirely met all our expectations and allowed successful completion of the project on small non coding RNA expression in renal cell carcinoma"
Prof. Jörg Ellinger, Klinik und Poliklinik für Urologie und Kinderurologie, Universitätsklinikum Bonn, Germany